Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri – Russia, 2019-10-28 11:13 (1673 d 10:00 ago) – Posting: # 20727
Views: 4,305

(edited by mittyri on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,035 posts in 4,835 threads, 1,644 registered users;
58 visitors (0 registered, 58 guests [including 5 identified bots]).
Forum time: 22:13 CEST (Europe/Vienna)

That which is static and repetitive is boring.
That which is dynamic and random is confusing.
In between lies art.    John Locke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5